• Home
  • NEW DAY MEDICINE
  • 5 (43) 2022
  • 48 -5 (43) 2022 — Nigmatullayeva M.A., Tilloyeva Sh.Sh. — COVID-19 AND BRONCHIAL ASTHMA (CLINICAL AND EPIDEMIOLOGICAL ASPECTS)

48 -5 (43) 2022 — Nigmatullayeva M.A., Tilloyeva Sh.Sh. — COVID-19 AND BRONCHIAL ASTHMA (CLINICAL AND EPIDEMIOLOGICAL ASPECTS)

COVID-19 AND BRONCHIAL ASTHMA (CLINICAL AND EPIDEMIOLOGICAL ASPECTS)

Nigmatullayeva M.A., Bukhara State Medical Institute, Uzbekistan

Tilloyeva Sh.Sh. Bukhara State Medical Institute, Uzbekistan

Resume

The review article combines modern knowledge about the origin, pathogenesis, epidemiology, clinical and laboratory diagnostics, as well as therapy and prevention of new coronavirus infection; describes the possible relationship of coronavirus infection with bronchial asthma, as well as possible options for the effect of coronavirus infection on the severity of bronchial asthma collected from publications of specialists of the Russian Federation and researchers from various countries.

Keywords: coronavirus infection, coronavirus, COVID-19, bronchial asthma, pandemic

First page

238

Last page

245

For citation: Nigmatullayeva M.A., Tilloyeva Sh.Sh. COVID-19 AND BRONCHIAL ASTHMA (CLINICAL AND EPIDEMIOLOGICAL ASPECTS) //New Day in Medicine 5(43)2022 238-245 https://clck.ru/mhh8J

LIST OF REFERENCES:

  1. World Health Organization. Asthma [Internet]. Geneva: WHO; 2020. Accessed October 20, 2020. https://www.who.int/ru/news-room/fact-sheets/detail/asthma
  2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469-478. https://doi.org/10.1111/j.1398-9995.2004.00526.x
  3. Diagnosing asthma: a 21st century challenge. Accessed June 03, 2020. https://www.asthma.org.uk/a54e6a69/globalassets/get-involved/external-affairs campaigns/diagnostics/diagnosing-asthma-21st-century-challenge.pdf
  4. Du Toit A. Outbreak of a novel coronavirus // Nat. Rev. Microbiol.2020. Vol. 18, N 3. Р. 123.
  5. Wang W., Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China // J. Med. Virol. 2020. Vol. 92, N 4. Р. 441–447.
  6. URL: https://www.ncbi.nlm.nih.gov/pubmed
  7. URL: http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1,GenBank accessionNo.MN908947.
  8. WHO Coronavirus disease (COVID-19) outbreak. URL: https://www. who.int/emergencies/diseases/novel-coronavirus-2019.
  9. Abrams E. M., Greenhawt M. Risk communication during COVID-19 // J. Allergy Clin. Immunol. Pract. – 2020. – Vol. 8, № 6. ‒ Р. 1791-1794. DOI: 10.1016/j.jaip.2020.04.012.
  10. Abrams E. M., Szefler S. J. Managing asthma during coronavirus disease-2019: an example for other chronic conditions in children and adolescents // J. Pediatr. – 2020. – Vol. 222. – Р. 221-226. DOI: 10.1016/j.jpeds.2020.04.049.
  11. Amirav I., Newhouse M. T. Transmission of coronavirus by nebulizer: a serious, underappreciated risk // CMAJ. – 2020. – Vol. 192, № 13. – Е346. DOI: 10.1503/cmaj.75066.
  12. Arabi Y. M., Mandourah Y., Al-Hameed F. et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome // Am. J. Respir. Crit. Care Med. – 2018. – Vol. 197, № 6. – Р. 757-767. DOI: 10.1164/rccm.201706-1172OC.
  13. Ari A. Promoting safe and effective use of aerosol devices in COVID-19: risks and suggestions for viral transmission // Expert. Opin. Drug. Deliv. – 2020. – Vol. 17, № 11. – Р. 1509-1513. DOI: 10.1080/17425247.2020.1811225.
  14. Avdeev S., Moiseev S., Brovko M. et al. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19 // Allergy. ‒ 2020. ‒ Vol. 75, № 10. ‒ Р. 2703-2704. DOI: 10.1111/all.14420.
  15. Bhatraju P. K., Ghassemieh B. J., Nichols M. et al. Covid-19 in critically ill patients in the Seattle region ‒ Case series // N. Engl. J. Med. – 2020. – Vol. 382, № 21. – Р. 2012-2022. DOI:10.1056/nejmoa2004500.
  16. Bousquet J., Bergmann K. C., Zuberbier T., Bedbrook A., Onorato G. L., Jutel M., Akdis C. A., Akdis M., Klimek L., Pfaar O., Nadeau K. C., Chinthrajah S., Eiwegger T., Ansotegui I. J., Anto J. M., Bachert C., Bateman E. D., Bennoor K. S., Berghea E. C., Blain H. et al. ARIA-EAACI statement on Asthma and COVID-19 (JUNE 2, 2020) // Allergy. ‒ 2021. ‒ Vol. 76, № 3. ‒ Р. 689-697. DOI: 10.1111/all.14471.
  17. Bozek A., Winterstein J. Montelukast’s ability to fight COVID-19 infection // J. Asthma. – 2020. – Р. 1-2. DOI:10.1080/02770903.2020.1786112.
  18. Brough H. A., Kalayci O., Sediva A. et al. Managing childhood allergies н Х immunodeficiencies during respiratory virus epidemics ‒ The 2020 COVID-19 pandemic: a statement from the EAACI-section on pediatrics // Pediatr. Allergy Immunol. – 2020. – Vol. 31, № 5. – Р. 442-448. DOI:10.1111/pai.13262.
  19. Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study // Lancet. – 2020. – Vol. 15, № 395. – Р. 507-513. DOI: 10.1016/S0140-6736(20)30211-7.
  20. Chhiba K. D., Patel G. B., Vu T. H. T. et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 // J. Allergy Clin. Immunol. – 2020. – Vol. 146, № 2. – Р. 307-314.e4. DOI:10.1016/j.jaci.2020.06.010.

file

download